Pentoxifylline
Pentoxifylline (BL-191), a haemorheological agent, is an orally active non-selective phosphodiesterase (PDE) inhibitor, with immune modulation, anti-inflammatory, hemorheological, anti-fibrinolytic and anti-proliferation effects. Pentoxifylline can be used for the research of peripheral vascular disease, cerebrovascular disease and a number of other conditions involving a defective regional microcirculation[1][2][3].
Product Specifications
CAS Number
[6493-05-6]
Product Name Alternative
BL-191; PTX; Oxpentifylline
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; HIV; Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Anti-infection; Autophagy; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cardiovascular Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Pentoxifylline.html
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 93.3 mg/mL (ultrasonic; warming)
Smiles
O=C(N1CCCCC(C)=O)N(C)C2=C(N(C)C=N2)C1=O
Molecular Formula
C13H18N4O3
Molecular Weight
278.31
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
